
evaluate the efficacy and safety profile of Rosuvastatin, Simvastatin and Atorvastatin in newly diagnosed type 2 diabetic patients with dyslipidaemia
Author(s) -
G. Dhone Pravin,
Gulati Rahul,
Sahu Padmini,
Mohd. Faheem Mubeen
Publication year - 2022
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns4.10009
Subject(s) - medicine , dyslipidemia , simvastatin , atorvastatin , rosuvastatin , type 2 diabetes mellitus , group b , diabetes mellitus , gastroenterology , group a , type 2 diabetes , lipid profile , insulin resistance , statin , endocrinology , insulin , cholesterol , obesity